Trial · NCT00707993
Results by group186
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 186
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Glycosylated Hemoglobin at Week 52. | Alogliptin 25 mg QD | -0.14 | Standard Error 0.063 | percentage of Glycosylated Hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin at Week 52. | Glipizide 5 mg QD | -0.09 | Standard Error 0.067 | percentage of Glycosylated Hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 4 (n=175; n=148) | -0.14 | Standard Error 0.047 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 4 (n=175; n=148) | -0.11 | Standard Error 0.051 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 8 (n=180; n=161) | -0.27 | Standard Error 0.051 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 8 (n=180; n=161) | -0.23 | Standard Error 0.054 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 12 (n=180; n=162) | -0.34 | Standard Error 0.053 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 12 (n=180; n=162) | -0.25 | Standard Error 0.055 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 16 (n=180; n=162) | -0.31 | Standard Error 0.050 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 16 (n=180; n=162) | -0.32 | Standard Error 0.052 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 20 (n=180; n=162) | -0.31 | Standard Error 0.051 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 20 (n=180; n=162) | -0.27 | Standard Error 0.054 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 26 (n=180; n=162) | -0.28 | Standard Error 0.052 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 26 (n=180; n=162) | -0.25 | Standard Error 0.055 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 34 (n=180; n=162) | -0.21 | Standard Error 0.056 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 34 (n=180; n=162) | -0.21 | Standard Error 0.059 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Alogliptin 25 mg QD | Week 42 (n=180; n=162) | -0.17 | Standard Error 0.062 | percentage of Glycosylated Hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin | Glipizide 5 mg QD | Week 42 (n=180; n=162) | -0.17 | Standard Error 0.065 | percentage of Glycosylated Hemoglobin |
| Incidence of Hypoglycemia | Alogliptin 25 mg QD | 5.4 | percentage of participants | ||
| Incidence of Hypoglycemia | Glipizide 5 mg QD | 26.0 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00707993/results